5 completed. 2 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Sincalide: new trials by email Literature Review of Sincalide trials Research Report on Sincalide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in Healthy Male Participants [14C] BMS-986278, KinevacĀ® - Healthy Volunteers | Phase 1 | Completed | Bristol-Myers Squibb | 9 | 2020-10-15 | 2022-06-02 |
| A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects Albiglutide 50 mg, Placebo, CCK (Kinevac) - Diabetes Mellitus, Type 2 | Phase 4 | Completed | GlaxoSmithKline | 20 | 2015-06-11 | 2018-04-05 |
| The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion Acetaminophen, Metformin, Colesevelam - To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion | Not applicable | Completed | Filip Krag Knop | 10 | 2012-07-01 | 2015-07-14 |
| Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs) Sincalide, Ursodiol, Fat Meal - Healthy Volunteers | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 31 | 2008-06-23 | 2020-07-22 |
| Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis sincalide - Cholestasis | Not applicable | Completed | University of Michigan | 252 | 1997-09-01 | 2015-03-25 |
Cholestasis (1) · Diabetes Mellitus, Type 2 (1) · Gastrointestinal Diseases (1) · Rare Diseases (1)
Bristol-Myers Squibb (1) · Filip Krag Knop (1) · GlaxoSmithKline (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of Michigan (1)
United States (4) · Denmark (1)
Daniel Hillel Teitelbaum (1) · Kong Y Chen, Ph.D. (1) · Ulrich Rohde, MD (1)